Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 6/2024

01-03-2024 | Acute Promyelocytic Leukemia | Letter to the Editor

Cystatin F a potential diagnostic biomarker in acute promyelocytic leukemia

Authors: Hamenth Kumar Palani, Saravanan Ganesan, Nithya Balasundaram, Arvind Venkatraman, Uday Kulkarni, Anu Korula, Sukesh C Nair, Thenmozhi Mani, Poonkuzhali Balasubramanian, Aby Abraham, Vinuth N Puttamallesh, Harsha Gowda, Vikram Mathews

Published in: Annals of Hematology | Issue 6/2024

Login to get access

Excerpt

Dear Editor, …
Appendix
Available only for authorised users
Literature
1.
Dimov ND, Medeiros LJ, Kantarjian HM et al (2010) Rapid and reliable confirmation of acute promyelocytic leukemia by immunofluorescence staining with an antipromyelocytic leukemia antibody: the M. D. Anderson Cancer Center experience of 349 patients. Cancer 116:369–376CrossRefPubMed
2.
Halfon S, Ford J, Foster J et al (1998) Leukocystatin, a new class II cystatin expressed selectively by hematopoietic cells. J Biol Chem 273:16400–16408CrossRefPubMed
3.
4.
5.
Obata-Onai A, Hashimoto S, Onai N et al (2002) Comprehensive gene expression analysis of human NK cells and CD8(+) T lymphocytes. Int Immunol 14:1085–1098CrossRefPubMed
6.
Bagger FO, Kinalis S, Rapin N (2019) BloodSpot: a database of healthy and malignant haematopoiesis updated with purified and single cell mRNA sequencing profiles. Nucleic Acids Res 47:D881–D885CrossRefPubMed
7.
Ni J, Fernandez MA, Danielsson L et al (1998) Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor. J Biol Chem 273:24797–24804CrossRefPubMed
Metadata
Title
Cystatin F a potential diagnostic biomarker in acute promyelocytic leukemia
Authors
Hamenth Kumar Palani
Saravanan Ganesan
Nithya Balasundaram
Arvind Venkatraman
Uday Kulkarni
Anu Korula
Sukesh C Nair
Thenmozhi Mani
Poonkuzhali Balasubramanian
Aby Abraham
Vinuth N Puttamallesh
Harsha Gowda
Vikram Mathews
Publication date
01-03-2024
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 6/2024
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-024-05673-4

Other articles of this Issue 6/2024

Annals of Hematology 6/2024 Go to the issue

Original Article

A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia

Research

Combining serum microRNAs and machine learning algorithms for diagnosing infectious fever after HSCT

Review Article

Coagulation and Inflammation in COVID-19: Reciprocal Relationship between Inflammatory and Coagulation Markers

Research

Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies

Case Report

Diagnosing aceruloplasminemia: navigating through red herrings

Original Article

Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits